Social Reality Stock News

Brokerages forecast that SRAX, Inc. (NASDAQ:SRAX) will report $10.05 million in sales for the current quarter, Zacks reports. Two analysts have issued estimates for SRAXs earnings, with estimates ranging from $10.00 million to $10.10 million. SRAX reported sales of $4.52 million during the same quarter last year, which would suggest a positive year-over-year growth rate []

Kelowna, British Columbia TheNewswire - December 16, 2021 Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) (the Company or Lexaria ), a global innovator in drug delivery platforms announces that it has entered into an advertising and media agreement (the Contract ) for media buys and digital marketing with SRAX, Inc. ( SRAX ). Lexaria is pleased to be working with SRAX to inform and engage a broad investor community in this significant, year-long media outreach campaign, said Chris Bunka, CEO of Lexaria Bioscience. Lexaria has made tremendous progress during 2021 and we expect even more significant advancement in 2022 and are pursuing the broadest possible investor involvement to ensure that Lexarias achievements are communicated to all investors. Lexaria is planning for 2022 to be its busiest year ever, with major studies and events already announced that include: a six-week human clinical hypertension study to evaluate DehydraTECH-CBD for possible relief of hypertension; an industry-leading oral nicotine human study including both subjective evaluation and objective blood measurements expected to demonstrate the superiority of DehydraTECH-nicotine compared to leading industry products; a program of animal studies designed to evaluate DehydraTECH-CBD for seizure relief and comparison against the only existing FDA-approved CBD medication currently in use for treatment of certain seizure disorders; and our expectation of completing a pre-IND meeting with the FDA, and subsequently filing an IND application, for registered clinical trial testing of DehydraTECH-CBD for hypertension.

SRAX, Inc. (NASDAQ:SRAX)s share price traded down 2.8% on Monday . The company traded as low as $4.18 and last traded at $4.24. 117,735 shares were traded during trading, a decline of 78% from the average session volume of 547,114 shares. The stock had previously closed at $4.36. SRAX has been the topic of several []

LOS ANGELES , Dec. 10, 2021 (GLOBE NEWSWIRE) -- -- via InvestorWire -- SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through

Charles Schwab survey shows 15% of retail investors started during the COVID-19 pandemic in 2020 SRAXs Sequire premier IR communications platform assists public companies understand and communicate with the investment community After following SRAX to understand its expertise, Sino American Oil Company has engaged SRAX More than 250 companies now use Sequire, driving revenue to Continue reading "As Older Population Starts Self-Directed Investing, O&G Company Engages SRAX Inc. (NASDAQ: SRAX) for Targeted Outreach" The post As Older Population Starts Self-Directed Investing, O&G Company Engages SRAX Inc. (NASDAQ: SRAX) for Targeted Outreach appeared first on NetworkNewsWire .

SRAX is growing substantially and produces operational profits. While it is paid partially in securities adding risk, especially in a down market, the company has plenty of sources of liquidity, shoul

SRAX, Inc. (NASDAQ:SRAX) was the recipient of a significant growth in short interest in October. As of October 29th, there was short interest totalling 673,100 shares, a growth of 15.4% from the October 14th total of 583,300 shares. Approximately 3.2% of the companys stock are short sold. Based on an average trading volume of 332,200 []

SRAX, Inc. (NASDAQ:SRAX) Research analysts at B. Riley issued their Q1 2022 earnings per share estimates for shares of SRAX in a report issued on Tuesday, November 16th. B. Riley analyst M. Crawford forecasts that the business services provider will post earnings per share of $0.07 for the quarter. B. Riley also issued estimates []

Cheyenne, WY, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Sino American Oil Company, (OTC PINK: OILY) $OILY, an emerging Oil and Gas exploration company, announces it has signed an agreement to engage SRAX (NASDAQ: SRAX) $SRAX, a digital marketing and consumer data-management technology company, to assist in its investor outreach and growth initiatives.

SRAX (SRAX) delivered earnings and revenue surprises of -475.00% and 0.83%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

LOS ANGELES--(BUSINESS WIRE)---- $SRAX #SRAX--SRAX, Inc. is providing unaudited financial results for Q3 on a call, today, November 15th, 2021 at 4:30 pm ET / 1:30 pm PT.

SRAX, Inc. (SRAX) CEO Christopher Miglino on Q3 2021 Results - Earnings Call Transcript

SRAX (SRAX) delivered earnings and revenue surprises of -475.00% and 0.83%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

SRAX (SRAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.